Communiqués Acarix AB

Actions

ACARIX

SE0009268717

Equipement et technologie médicale avancés

PEA

Marché Fermé - Nasdaq Stockholm 18:00:00 28/09/2026			Varia. 5j.	Varia. 1 janv.
0,1866 ^SEK	-7,16 %		-10,72 %	-30,37 %

24/09	25 actions ont jusqu’à présent inscrit aujourd’hui un nouveau plus bas sur 52 semaines à la Bourse de Stockholm	FW
17/09	Neuf actions ont inscrit un nouveau plus bas de 52 semaines aujourd'hui à la Bourse de Stockholm	FW

Communiqués

14/09	Acarix: Seismocardiography gains further validation in heart failure	AQ
11/09	Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far Fewer False Positives Than Standard Blood Test	AQ
17/08	Acarix (Q2 Review): Laying the groundwork	AQ
13/08	Acarix (Q2 Initial take): In line with estimates	AQ
13/08	Acarix Publishes Second Quarter and First Half 2026 Results	AQ
11/08	Acarix Receives Regulatory Approval for the CADScor(R) System in the UAE (United Arab Emirates)	AQ
10/08	Acarix Receives Regulatory Approval for the CADScor®System in the United Arab Emirates	AQ
17/06	Announcement from the annual general meeting in Acarix AB	AQ
16/06	Proposals of the Nomination Committee for the Annual General Meeting of Acarix AB (publ) on June 17, 2026	AQ
19/05	Acarix (Q1 Review): Continued US traction and improved cost base	AQ
19/05	Acarix : Notice AGM 2029 (ENG) (Notice Acarix AB final 2026 05 1818540034)	PU
18/05	NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB	AQ
18/05	Acarix : Q1 2026 (Acarix Q12026 English Report 2605150747 FINAL)	PU
18/05	Acarix Publishes Interim Report, January – March 2026	AQ
04/05	Acarix Changes Publication Date for Q1 2026 Interim Report	AQ
15/04	Acarix AB’s Annual Report 2025	AQ
15/04	Acarix : 2025 ANNUAL REPORT-ENGLISH (Acarix English Annual 2025 Report Final)	PU
08/04	ACARIX PRESENTS ABSTRACT AT ACC.26 HIGHLIGHTING CADSCOR® SYSTEM'S DIAGNOSTIC UTILITY COMPARED TO STANDARD STRESS TESTS IN CHEST PAIN PATIENTS	AQ
13/02	Acarix (Q4 review): A solid end to 2025	AQ
12/02	Acarix Publishes Year-End Report 2025	AQ
12/02	Acarix : Q4 2025 (Acarix Q4 Interim Report Final)	PU
11/02	Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System	AQ
04/02	Acarix Receives EU MDR Certification for the CADScor®System	AQ
08/12	ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF APPROX. SEK 33.4 MILLION	AQ
06/11	Invitation to presentation of Acarix´s third quarter 2025 report	AQ